Clinical Cancer Research The Future of Cancer Research: Science and Patient Impact
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Garcia-Manero, G.
Right arrow Articles by Issa, J.-P. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Garcia-Manero, G.
Right arrow Articles by Issa, J.-P. J.
Clinical Cancer Research Vol. 8, 1897-1903, June 2002
© 2002 American Association for Cancer Research


Molecular Oncology, Markers, Clinical Correlates

DNA Methylation Patterns at Relapse in Adult Acute Lymphocytic Leukemia1

Guillermo Garcia-Manero2, Carlos Bueso-Ramos, Jerry Daniel, Jason Williamson, Hagop M. Kantarjian and Jean-Pierre J. Issa

Departments of Leukemia [G. G-M., J. D., J. W., H. M. K., J-P. J. I.] and Hematopathology [C. B-R.], University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030

Purpose: Aberrant DNA methylation of promoter-associated CpG islands is an epigenetic DNA modification observed in acute leukemias that in certain cases has been associated with a poor prognosis and increased relapse rates. To study the role of DNA methylation in relapse mechanisms in acute lymphocytic leukemia (ALL), we have compared the methylation status of five genes at the time of initial presentation and at first relapse in 25 adult patients with ALL.

Experimental Design: Genes studied included the estrogen receptor (ER), multidrug resistance gene 1 (MDR1), p73, p15, and p16. DNA was extracted from paraffin-embedded bone marrow biopsies. DNA methylation was analyzed using PCR of bisulfite-modified DNA.

Results: Results indicate that methylation at the time of relapse was stable in 92% of patients for p73, 88% for ER, 80% for p16, 72% for MDR1, and 60% for p15. Only one case had p16 methylation at initial presentation, whereas 6 patients (P = 0.0001) had methylation at relapse. Three cases had concomitant methylation of p15 and p16 at relapse. The degree of MDR1 methylation inversely correlated with the presence of MDR1 expression as detected by immunohistochemistry. Eighteen patients (72%) had acquired no or one methylation change, whereas the rest (28%) had methylation changes in two or three genes. No clinical-biological correlations were found between methylation of any particular gene or pattern.

Conclusions: In summary, DNA methylation patterns are stable in a majority of patients with relapsed ALL, but a subset of patients acquire new methylation changes, in particular affecting cell cycle regulatory genes.




This article has been cited by other articles:


Home page
BloodHome page
A. Scuto, M. Kirschbaum, C. Kowolik, L. Kretzner, A. Juhasz, P. Atadja, V. Pullarkat, R. Bhatia, S. Forman, Y. Yen, et al.
The novel histone deacetylase inhibitor, LBH589, induces expression of DNA damage response genes and apoptosis in Ph- acute lymphoblastic leukemia cells
Blood, May 15, 2008; 111(10): 5093 - 5100.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
C. Bueso-Ramos, Y. Xu, T. J. McDonnell, S. Brisbay, S. Pierce, H. Kantarjian, G. Rosner, and G. Garcia-Manero
Protein Expression of a Triad of Frequently Methylated Genes, p73, p57Kip2, and p15, Has Prognostic Value in Adult Acute Lymphocytic Leukemia Independently of Its Methylation Status
J. Clin. Oncol., June 10, 2005; 23(17): 3932 - 3939.
[Abstract] [Full Text] [PDF]


Home page
ASH ANNUAL MEETING ABSTRACTSHome page
K. Hoshino, H. Yang, B. Sanchez-Gonzalez, and G. Garcia-Manero
Detection of Aberrant DNA Methylation in Acute Lymphocytic Leukemia (ALL) Using a Real-Time Polymerase Chain Reaction (PCR) Assay.
Blood (ASH Annual Meeting Abstracts), November 16, 2004; 104(11): 998 - 998.
[Abstract]


Home page
Clin. Cancer Res.Home page
S. S. Liu, R. C.-Y. Leung, K. Y.-K. Chan, P.-M. Chiu, A. N.-Y. Cheung, K.-F. Tam, T.-Y. Ng, L.-C. Wong, and H. Y.-S. Ngan
p73 Expression Is Associated with the Cellular Radiosensitivity in Cervical Cancer after Radiotherapy
Clin. Cancer Res., May 15, 2004; 10(10): 3309 - 3316.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
S. Zheng, X. Ma, L. Zhang, L. Gunn, M. T. Smith, J. L. Wiemels, K. Leung, P. A. Buffler, and J. K. Wiencke
Hypermethylation of the 5' CpG Island of the FHIT Gene Is Associated with Hyperdiploid and Translocation-Negative Subtypes of Pediatric Leukemia
Cancer Res., March 15, 2004; 64(6): 2000 - 2006.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
L. Shen, M. Toyota, Y. Kondo, T. Obata, S. Daniel, S. Pierce, K. Imai, H. M. Kantarjian, J.-P. J. Issa, and G. Garcia-Manero
Aberrant DNA methylation of p57KIP2 identifies a cell-cycle regulatory pathway with prognostic impact in adult acute lymphocytic leukemia
Blood, May 15, 2003; 101(10): 4131 - 4136.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
A. El-Osta, M. Lubbert, P. W. Wijermans, T. Licht, and P. A. Jones
On the use of DNA methylation inhibitors and the reversal of transcriptional silencing
Blood, February 15, 2003; 101(4): 1656 - 1657.
[Full Text] [PDF]


Home page
BloodHome page
L. Shen, Y. Kondo, J.-P. Issa, G. Garcia-Manero, J. Roman-Gomez, J. A. Castillejo, A. Torres, and A. Jimenez
Lack of p21CIP1 DNA methylation in acute lymphocytic leukemia
Blood, October 16, 2002; 100(9): 3432 - 3433.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2002 by the American Association for Cancer Research.